Table 2 Summarized data for each control and test group.
From: Multiparametric in vitro and in vivo analysis of the safety profile of self-assembling peptides
Group | References | Animals at the start of the test (n) | Adverse clinical signs (n) | Body weights at the beginning of the experiment (means) | Body weight at the end of the experiment (means) |
|---|---|---|---|---|---|
HS | 5 | 0 | 255.6 ± 8.25 g | 261.8 ± 15.5 g | |
68 | 5 | 0 | 238.1 ± 8.05 g | 247.9 ± 7.60 g | |
46 | 5 | 0 | 250.5 ± 9.10 g | 265.2 ± 8.20 g | |
C1 | 5 | 0 | 238.8 ± 20.3 g | 260.4 ± 19.5 g | |
65L | 5 | 0 | 251.6 ± 19.7 g | 271.8 ± 20.6 g | |
B42 | 5 | 0 | 243.8 ± 9.10 g | 260.8 ± 10.9 g | |
Control | 5 | 0 | 249.1 ± 16.1 g | 264.1 ± 17.2 g |
